386 related articles for article (PubMed ID: 34087397)
1. Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis.
Bi Y; Han X; Lai Y; Fu Y; Li K; Zhang W; Wang Q; Jiang X; Zhou Y; Liang H; Fan H
J Ethnopharmacol; 2021 Oct; 278():114278. PubMed ID: 34087397
[TBL] [Abstract][Full Text] [Related]
2. Explore bioactive ingredients and potential mechanism of Houpo Mahuang decoction for chronic bronchitis based on UHPLC-Q exactive orbitrap HRMS, network pharmacology, and experiment verification.
Gao F; Zhang T; Zhang H; Dai Z; Gu Y; Lu M; Zhang Z; Zeng Q; Shang B; Gao S; Wang N; Xu B; Lei H
J Ethnopharmacol; 2023 Mar; 303():115924. PubMed ID: 36414217
[TBL] [Abstract][Full Text] [Related]
3. Danggui-Shaoyao San alleviates cognitive impairment via enhancing HIF-1α/EPO axis in vascular dementia rats.
Ningning Y; Ying X; Xiang L; Yue S; Zhongda W; Ruoyu J; Hanwen S; Weiwei T; Yafeng Z; Junjie M; Xiaolan C
J Ethnopharmacol; 2024 Sep; 331():118306. PubMed ID: 38723920
[TBL] [Abstract][Full Text] [Related]
4. Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation.
Pan Y; Feng X; Song W; Zhou X; Zhou Z; Chen G; Shen T; Zhang X
Drug Des Devel Ther; 2023; 17():597-612. PubMed ID: 36866196
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the mechanism of Danggui-Shaoyao-San in regulating the metabolome of nephrotic syndrome based on urinary metabonomics and bioinformatics approaches.
Wang Y; Fan S; Yang M; Shi G; Hu S; Yin D; Zhang Y; Xu F
J Ethnopharmacol; 2020 Oct; 261():113020. PubMed ID: 32592886
[TBL] [Abstract][Full Text] [Related]
6. Integrated UPLC-Q-TOF-MS and network pharmacology approach-driven quality marker discovery of Danggui Shaoyao San for primary dysmenorrhea.
Li Z; Xiong H; Li N; Zhao L; Liu Z; Yu Y; Zhao C
Biomed Chromatogr; 2023 May; 37(5):e5608. PubMed ID: 36805594
[TBL] [Abstract][Full Text] [Related]
7. Revealing active ingredients, potential targets, and action mechanism of Ermiao fang for treating endometritis based on network pharmacology strategy.
Zhang C; Su T; Yu D; Wang F; Yue C; Wang HQ
J Ethnopharmacol; 2020 Oct; 260():113051. PubMed ID: 32505843
[TBL] [Abstract][Full Text] [Related]
8. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
[TBL] [Abstract][Full Text] [Related]
9. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway.
Wu Y; Fang Y; Li Y; Au R; Cheng C; Li W; Xu F; Cui Y; Zhu L; Shen H
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117323. PubMed ID: 37852337
[TBL] [Abstract][Full Text] [Related]
10. Exploring the mechanism of Danggui Buxue Decoction in regulating atherosclerotic disease network based on integrated pharmacological methods.
Xu H; Zhang T; He L; Yuan M; Yuan X; Wang S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34528665
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease.
Chen Y; Song X; Luo Y; Li G; Luo Y; Wang Z; He R; Lu J; Xiong G; Cheng H; Li H; Yang S
Evid Based Complement Alternat Med; 2023; 2023():9208017. PubMed ID: 36636607
[TBL] [Abstract][Full Text] [Related]
13. Stepwise tracking strategy to screen ingredient from Galla Chinensis based on the "mass spectrometry guided preparative chromatography coupled with systems pharmacology".
Wang Z; Xue R; Lv M; Qi Y; Yu W; Xie Z; Chen W; Wang X; Tian X; Han B
J Ethnopharmacol; 2022 Feb; 284():114533. PubMed ID: 34728319
[TBL] [Abstract][Full Text] [Related]
14. Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease.
Yang J; Li C; Liu Y; Han Y; Zhao H; Luo S; Zhao C; Jiang N; Yang M; Sun L
Front Pharmacol; 2022; 13():832299. PubMed ID: 36059953
[TBL] [Abstract][Full Text] [Related]
15. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
Ji W; Wang T; Xu Y; An R; Liang K; Wang X
Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease.
Wu Q; Chen Y; Gu Y; Fang S; Li W; Wang Q; Fang J; Cai C
BMC Complement Med Ther; 2020 Sep; 20(1):282. PubMed ID: 32948180
[TBL] [Abstract][Full Text] [Related]
17. A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: Take Tangshen formula as an example.
Wang X; Zhou W; Wang Q; Zhang Y; Ling Y; Zhao T; Zhang H; Li P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122889. PubMed ID: 34626904
[TBL] [Abstract][Full Text] [Related]
18. Quality markers based on phytochemical analysis and anti-inflammatory screening: An integrated strategy for the quality control of Dalbergia odorifera by UHPLC-Q-Orbitrap HRMS.
Sun K; Su C; Li W; Gong Z; Sha C; Liu R
Phytomedicine; 2021 Apr; 84():153511. PubMed ID: 33652358
[TBL] [Abstract][Full Text] [Related]
19. Qinlian hongqu decoction ameliorates hyperlipidemia via the IRE1-α/IKKB-β/NF-κb signaling pathway: Network pharmacology and experimental validation.
Zhang Y; Guo Z; Wang J; Yue Y; Yang Y; Wen Y; Luo Y; Zhang X
J Ethnopharmacol; 2024 Jan; 318(Pt A):116856. PubMed ID: 37406747
[TBL] [Abstract][Full Text] [Related]
20. Danggui-Shaoyao-San (DSS) ameliorates the progression of osteoarthritis via suppressing the NF-κB signaling pathway: an
Chen S; Kang P; Zhao Z; Zhang H; Li J; Xu K; Gong D; Jiao F; Wang H; Zhang M
Aging (Albany NY); 2024 Jan; 16(1):648-664. PubMed ID: 38194722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
